🔊 Listen to the summary
Nanoparticles face significant challenges when targeting ovarian cancer cells, according to research reported by Phys.org.
While nanomedicine continues to be investigated as a method to deliver therapies directly to tumors, the biological interaction between engineered nanoparticles and ovarian cancer cells presents persistent difficulties that hinder effective delivery.
Source: phys.org



